Department of Pharmacology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
PLoS One. 2011;6(8):e24291. doi: 10.1371/journal.pone.0024291. Epub 2011 Aug 29.
Increasing evidence has pointed to activated type I interferon signaling in tumors. However, the molecular basis for such activation and its role in tumorigenesis remain unclear. In the current studies, we report that activation of type I interferon (IFN) signaling in tumor cells is primarily due to elevated secretion of the type I interferon, IFN-β. Studies in oncogene-transformed cells suggest that oncogenes such as Ras and Src can activate IFN-β signaling. Significantly, elevated IFN-β signaling in Ras-transformed mammary epithelial MCF-10A cells was shown to contribute to Ras transformation as evidenced by morphological changes, anchorage-independent growth, and migratory properties. Our results demonstrate for the first time that the type I IFN, IFN-β, contributes to Ras transformation and support the notion that oncogene-induced cytokines play important roles in oncogene transformation.
越来越多的证据表明,肿瘤中存在激活的 I 型干扰素信号。然而,这种激活的分子基础及其在肿瘤发生中的作用仍不清楚。在目前的研究中,我们报告称,肿瘤细胞中 I 型干扰素(IFN)信号的激活主要是由于 I 型干扰素 IFN-β 的分泌增加。在癌基因转化细胞中的研究表明,癌基因如 Ras 和 Src 可以激活 IFN-β 信号。重要的是,Ras 转化的 MCF-10A 乳腺上皮细胞中 IFN-β 信号的升高被证明有助于 Ras 转化,这表现在形态变化、非锚定依赖性生长和迁移特性方面。我们的结果首次表明,I 型干扰素 IFN-β 有助于 Ras 转化,并支持这样一种观点,即癌基因诱导的细胞因子在癌基因转化中发挥重要作用。